Share the post "Mutual Fund Data: Stock Market Insights on – 26 Sep -Amrutanjan Health Care"
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
 |
Gulf Oil Lubricants India | Aditya Birla Sun Life Insurance Company | Buy | 925K | 1351.00 | Gulf Oil International Mauritius Inc |
| Iti Mutual Fund | Buy | 296K | 1351.00 | Gulf Oil International Mauritius Inc | ||
 |
Amrutanjan Health Care | Icici Prudential Mutual Fund | Buy | 650K | 760.00 | Nageswaramma Private Trust |
The 925K shares of Gulf Oil Lubricants India have been purchased by the by Aditya Birla Sun Life Insurance Company through mutual funds at a price of ₹1351.00 per shareand it is sold by Gulf Oil International Mauritius Inc at a price of ₹1351.00 per share.
The 650K shares of Amrutanjan Health Care have been purchased by the by Icici Prudential Mutual Fund through mutual funds at a price of ₹760.00 per shareand it is sold by Nageswaramma Private Trust at a price of ₹760.00 per share.
The 296K shares of Gulf Oil Lubricants India have been purchased by the by Iti Mutual Fund through mutual funds at a price of ₹1351.00 per shareand it is sold by Gulf Oil International Mauritius Inc at a price of ₹1351.00 per share.
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
|
Gulf Oil Lubricants India | Aditya Birla Sun Life Insurance Company | Buy | 925K | 1351 | Gulf Oil International Mauritius Inc |
| Iti Mutual Fund | Buy | 296K | 1351 | Gulf Oil International Mauritius Inc | ||
| Jm Financial Mutual Fund | Buy | 148K | 1351 | Gulf Oil International Mauritius Inc | ||
| Uti Mutual Fund | Buy | 78K | 1351 | Gulf Oil International Mauritius Inc | ||
 |
Five-star Business Finance | Hdfc Mutual Fund | Buy | 834K | 800.5 | Norwest Venture Partners X Mauritius |
| Hdfc Mutual Fund | Buy | 417K | 800.5 | Norwest Venture Partners X Mauritius |
Gulf Oil Lubricants India shares totaling 925K were purchased by the by Aditya Birla Sun Life Insurance Company of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.Five-star Business Finance shares totaling 834K were purchased by the by Hdfc Mutual Fund of MutualFund, with the transaction occurring at a price of ₹800.5 per share. Subsequently, the shares were sold by Norwest Venture Partners X Mauritius at the same price per share.Five-star Business Finance shares totaling 417K were purchased by the by Hdfc Mutual Fund of MutualFund, with the transaction occurring at a price of ₹800.5 per share. Subsequently, the shares were sold by Norwest Venture Partners X Mauritius at the same price per share.
Gulf Oil Lubricants India shares totaling 296K were purchased by the by Iti Mutual Fund of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.Gulf Oil Lubricants India shares totaling 148K were purchased by the by Jm Financial Mutual Fund of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.Gulf Oil Lubricants India shares totaling 78K were purchased by the by Uti Mutual Fund of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.
Gulf Oil Lubricants India Limited
8,850.73
Net Sales
880.23
Net Profit
9,023.59
Total Income
7,841.59
Expenditure
1,397
Current Price
6,878
Market Cap
The financial snapshot for Gulf Oil Lubricants India Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹8,850.73 million and total income was ₹9,023.59 million. The company's expenditure was ₹7,841.59 million, leading to a net profit of ₹880.23 million. Earnings per Share (EPS) for continuing operations were ₹17.90. The report also highlights other income of ₹172.86 million, finance costs of ₹45.09 million, and employee benefit expenses of ₹407.10 million. Depreciation and amortization costs were ₹108.21 million, while current and deferred taxes were ₹311.88 million and ₹-10.10 million, respectively. The total comprehensive income for the period stood at ₹876.29 million, with other comprehensive income net of taxes at ₹-3.94 million.
Valued at ₹6,878 crore, the company's stock trades at ₹1,397, with historical highs and lows of ₹1,514 / 521. The P/E ratio of 21.3 reflects a high stock valuation. The book value is ₹263, and the dividend yield is 2.58%. ROCE is at 26.5%, and ROE is 24.7%. The company’s minimal debt-to-equity ratio of 0.28 contrasts with its negative net cash flow of ₹52.9 crore. The Piotroski score is 6.00, and the Graham Number of ₹627 provides insight into the stock’s valuation. The Price-to-Book (P/B) ratio of 5.30 indicates a premium valuation.
Amrutanjan Health Care Limited
0.00
Net Sales
46.16
Net Profit
881.88
Total Income
-818.39
Expenditure
754
Current Price
2,181
Market Cap
For Amrutanjan Health Care Limited, the latest financial data showcases impressive results. The company reported net sales of ₹0.00 million and total income of ₹881.88 million for the quarter. Expenditure was ₹-818.39 million, resulting in a net profit of ₹46.16 million. EPS for continuing operations was ₹1.60. Additional financial details include other income of ₹44.52 million, finance costs of ₹-0.65 million, and employee benefit expenses of ₹-138.59 million. Depreciation and amortization expenses were ₹-15.87 million. Current tax was ₹-19.21 million and deferred tax amounted to ₹1.88 million. Total comprehensive income for the period was ₹0.00 million, with other comprehensive income net of taxes at ₹0.00 million.
With a market capitalization of ₹2,181 crore, the company’s stock is currently priced at ₹754. The historical trading range of the stock is ₹863 / 556. The P/E ratio is remarkably high at 107, suggesting a significant valuation. The book value stands at ₹37.2, and the dividend yield is 0.62%. The Return on Capital Employed (ROCE) is 31.4%, and the Return on Equity (ROE) is 20.0%. The debt-to-equity ratio is very low at 0.02, though the company shows a negative net cash flow of ₹11.8 crore. The Piotroski score is 8.00, with the Graham Number pegged at ₹76.8. The Price-to-Book (P/B) ratio of 20.2 highlights a premium valuation.
Five-Star Business Finance Limited
6,661.44
Net Sales
2,515.70
Net Profit
6,693.81
Total Income
3,331.94
Expenditure
785
Current Price
22,958
Market Cap
In Five-Star Business Finance Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹6,661.44 million, with total income of ₹6,693.81 million. The expenditure was ₹3,331.94 million, leading to a net profit of ₹2,515.70 million. Earnings per Share (EPS) for continuing operations were reported at ₹8.60. The financial overview also includes other income of ₹32.38 million, finance costs of ₹1,581.90 million, and employee benefit expenses totaling ₹1,228.13 million. Depreciation and amortization expenses were ₹63.75 million. Current and deferred taxes were recorded at ₹918.77 million and ₹-72.60 million, respectively. The total comprehensive income for the period was ₹2,510.79 million, and other comprehensive income net of taxes was ₹-4.91 million.
Currently valued at ₹22,958 crore, the company's stock price is ₹785. It has seen a price range of ₹863 / 600 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 147, implying a strong valuation. The book value per share is ₹ and the dividend yield is 0.00%. ROCE is recorded at 17.0%, and ROE stands at 16.0%. The company maintains a very low debt-to-equity ratio of 0.70, though it has a negative net cash flow of ₹88.2 crore. The Piotroski score of 4.00 and the Graham Number of ₹ suggest some caution, while the Price-to-Book (P/B) ratio of reflects a premium valuation.
